The first publication I published internationally was on Clostridium perfringens enterotoxin (CPE) in 1977, and my PhD is on CPE. At the ‘First European Workshop on Bacterial Protein Toxins’ (Seillac, France, June 1983), I got an update on the food poisoning caused by Bacillus cereus, and was surprised how little that was known about both the emetic- and diarrhoeal syndrome. I actually decided then that I would like to follow up on the B. cereus toxins, but I mostly focused on the CPE for many years to come. Two years later at the ‘Second European Workshop on Bacterial Protein Toxins’ (Wepion, Belgium, July, 1985), I was invited speaker, and gave the talk: ‘Structure and mechanism of action of the enterotoxin from Clostridium perfringens type A’. At this conference, I talked with Dr David Ellar from University of Cambridge, UK, and members of his group. Dr Ellar's group was working on B. thuringiensis δ-endotoxins. The following year the ‘bacterial genetic revolution’ hit our laboratory at Norwegian Food Research Institute, and as a microbiologist/protein chemist, I needed to make a choice: Weather or not to follow up on microbial genetics. I applied for a sabbatical year, which I got (1986/87) and contacted Dr Ellar about working in his laboratory on B. thuringiensis δ-endotoxins. I was accepted and moved to Cambridge late June 1986, for a year. My plans was to work on B. cereus after returning home and with the very close relationship between B. cereus and B. thuringiensis, I got to the best possible environment in Cambridge. This year also resulted in my first paper using microbial genetics (Granum, Pinnavaia and Ellar 1988)
No takes yet. Share an insight, caveat, or question.
Per Einar Granum (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: